« Previous
Next »
Titles
- M10: bioanalytical method validation and study sample analysis : guidance for industry1
- M7(R2) assessment and control of DNA reactive (mutagenic) impurities in pharmaceuticals to limit potential carcinogenic risk: guidance for industry1
- Managed care1
- Mandated benefits1
- Manufacturers may need additional guidance to ensure consistent calculations of average sales prices1
- Many Medicaid enrollees with opioid use disorder were treated with medication: however, disparities present concerns1
- Markets or monopolies?: considerations for addressing health care consolidation in California1
- Maternal health: Availability of hospital-based obstetric care in rural areas : report to congressional committees1
- Maternal health: Outcomes worsened and disparities persisted during the pandemic : report to congressional addressees1
- Maternal mortality and morbidity: additional efforts needed to assess program data for rural and underserved areas : report to the Committee on Ways and Means, House of Representatives1
- Maternal mortality: trends in pregnancy-related deaths and federal efforts to reduce them : Congressional requesters1
- Medicaid Fraud Control Units fiscal year 2018 annual report1
- Medicaid Fraud Control Units fiscal year 2019 annual report1
- Medicaid Fraud Control Units fiscal year 2020 annual report1
- Medicaid Fraud Control Units fiscal year 2022 annual report1
- Medicaid Fraud Control Units: investigation and prosecution of fraud and beneficiary abuse in Medicaid personal care services1
- Medicaid Managed Care: Rapid spending growth in state directed payments needs enhanced oversight and transparency : report to congressional addressees1
- Medicaid behavioral health: CMS guidance needed to better align demonstration payment rates with costs and prevent duplication : report to Congressional committees1
- Medicaid demonstrations: actions needed to address weaknesses in oversight of costs to administer work requirements : report to Congressional requesters1
- Medicaid demonstrations: federal action needed to improve oversight of spending : report to the Chairman, Committee on Finance, U.S. Senate1